2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 10:21, 18 December 2023
, 18 December 2023→Effect
(→Effect) |
|||
| Line 118: | Line 118: | ||
! | ! | ||
! rowspan="3" |After | ! rowspan="3" |After | ||
! colspan=" | ! colspan="3" |NMN Group | ||
! colspan=" | ! colspan="3" |Placebo Group | ||
!NMN group | !NMN group | ||
|- | |- | ||
! | ! | ||
! colspan=" | ! colspan="3" |NAD+ concentrate [µM] | ||
! colspan=" | ! colspan="3" |NAD+ concentrate [µM] | ||
!NAMN | !NAMN | ||
|- | |- | ||
| Line 130: | Line 130: | ||
!Baseline | !Baseline | ||
!After | !After | ||
!Factor | |||
!Baseline | !Baseline | ||
!After | !After | ||
!Factor | |||
!After | !After | ||
|- | |- | ||
| Line 138: | Line 140: | ||
|0.176±0.063 | |0.176±0.063 | ||
|1.07±0.16 | |1.07±0.16 | ||
|6.1 | |||
|0.194±0.081 | |0.194±0.081 | ||
|0.53±0.12 | |0.53±0.12 | ||
|2.7 | |||
|3.51±1.86 | |3.51±1.86 | ||
|- | |- | ||
| Line 146: | Line 150: | ||
|~22 | |~22 | ||
|~38 | |~38 | ||
|1.72 | |||
|~21 | |~21 | ||
|~22 | |~22 | ||
|~1 | |||
|~1.45 | |~1.45 | ||
|- | |- | ||
| Line 154: | Line 160: | ||
|0.006 (mean) | |0.006 (mean) | ||
|0.026 (mean) | |0.026 (mean) | ||
|(4.3) | |||
| | |||
| | | | ||
| | | | ||
| Line 162: | Line 170: | ||
|14.81±11.68 | |14.81±11.68 | ||
|21.19±11.83 | |21.19±11.83 | ||
|1.43 | |||
|16.20±10.37 | |16.20±10.37 | ||
|16.15±8.56 | |16.15±8.56 | ||
|~1 | |||
| | | | ||
|} | |} | ||